» Articles » PMID: 35975576

BSACI Guideline for the Diagnosis and Management of Pollen Food Syndrome in the UK

Overview
Date 2022 Aug 17
PMID 35975576
Authors
Affiliations
Soon will be listed here.
Abstract

Pollen food syndrome (PFS) is a highly prevalent food allergy affecting pollen-sensitized children and adults. Sufferers experience allergic symptoms when consuming raw plant foods, due to the homology between the pollen allergens and unstable proteins in these foods. The triggers involved can vary depending on the pollen sensitization, which in turn is affected by geographical location. The British Society of Allergy and Clinical Immunology (BSACI) Standards of Care Committee (SOCC) identified a need to develop a guideline for the diagnosis and management of PFS in the United Kingdom (UK). Guidelines produced by the BSACI use either the GRADE or SIGN methodology; due to a lack of high-quality evidence these recommendations were formulated using the SIGN guidelines, which is acknowledged to be less robust than the GRADE approach. The correct diagnosis of PFS ensures the avoidance of a misdiagnosis of a primary peanut or tree nut allergy or confusion with another plant food allergy to non-specific lipid transfer proteins. The characteristic foods involved, and rapid-onset oropharyngeal symptoms, mean PFS can often be diagnosed from the clinical history alone. However, reactions involving tree nuts, peanuts and soya milk or severe/atypical reactions to fruits and vegetables may require additional diagnostic tests. Management is through the exclusion of known trigger foods, which may appear to be simple, but is highly problematic if coupled with a pre-existing food allergy or for individuals following a vegetarian/vegan diet. Immunotherapy to pollens is not an effective treatment for PFS, and although oral or sublingual immunotherapy to foods seems more promising, large, controlled studies are needed. The typically mild symptoms of PFS can lead to an erroneous perception that this condition is always easily managed, but severe reactions can occur, and anxiety about the onset of symptoms to new foods can have a profound effect on quality of life.

Citing Articles

Tree Nut Allergy in Children-What Do We Know? -A Review.

Chudoba A, Zebrowska A, Sybilski A Nutrients. 2024; 16(23).

PMID: 39683372 PMC: 11643764. DOI: 10.3390/nu16233978.


Evaluation of the protocol for rush subcutaneous immunotherapy with birch pollen extract.

Hamada M, Kagawa M, Tanaka I Asia Pac Allergy. 2024; 14(4):214-219.

PMID: 39624447 PMC: 11608609. DOI: 10.5415/apallergy.0000000000000164.


An International Delphi Consensus on the Management of Pollen-Food Allergy Syndrome: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee.

Al-Shaikhly T, Cox A, Nowak-Wegrzyn A, Cianferoni A, Katelaris C, Ebo D J Allergy Clin Immunol Pract. 2024; 12(12):3242-3249.e1.

PMID: 39488768 PMC: 11625607. DOI: 10.1016/j.jaip.2024.09.037.


EAACI guidelines on the management of IgE-mediated food allergy.

Santos A, Riggioni C, Agache I, Akdis C, Akdis M, Alvarez-Perea A Allergy. 2024; 80(1):14-36.

PMID: 39473345 PMC: 11724237. DOI: 10.1111/all.16345.


The effect of subcutaneous and sublingual birch pollen immunotherapy on birch pollen-related food allergy: a systematic review.

Kallen E, Welsing P, Lowik J, Van Ree R, Knulst A, Le T Front Allergy. 2024; 5:1360073.

PMID: 38903704 PMC: 11187334. DOI: 10.3389/falgy.2024.1360073.